Showing results (71-80 of 316) with videos related to

Sort By:
Pageof 32
International Journal of Clinical Oncology|June 17, 2011
Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese populationYasuhiro Hashimoto, Akiko Okamoto, Atsushi Imai, et al.
Cancer Science|December 19, 2015
I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signalingJotaro Mikami, Yuki Tobisawa, Tohru Yoneyama, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 19, 2007
[Adenocarcinoma of the ileal segment 40 years after ileocystoplasty: a case report]Takahiro Yoneyama, Akiko Okamoto, Atsushi Imai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 29, 2019
Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancerTakuya Koie, Chikara Ohyama, Kazuhide Makiyama, et al.
International Urology and Nephrology|September 2, 2020
Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institutionTakuya Koie, Yasuhiro Hashimoto, Atsushi Imai, et al.
Scientific Reports|January 28, 2022
Gene therapy of prostate cancer using liposomes containing perforin expression vector driven by the promoter of prostate-specific antigen geneKosuke Mizutani, Kyojiro Kawakami, Yasunori Fujita, et al.
Japanese Journal of Clinical Oncology|October 30, 2024
The prognostic superiority of second-generation androgen receptor signaling inhibitor in patients with non-metastatic castration-resistant prostate cancerTaku Naiki, Kiyoshi Takahara, Hiromitsu Watanabe, et al.
Cancers|November 25, 2023
The Geriatric Nutritional Risk Index Predicts Prognosis in Japanese Patients with LATITUDE High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Multi-Center StudyTaku Naiki, Kiyoshi Takahara, Hiromitsu Watanabe, et al.
Urology Case Reports|March 27, 2026
Bladder sarcomatoid carcinoma and giant cell carcinoma without recurrence after robot-assisted radical cystectomy: A case reportTomoki Taniguchi, Masayuki Tomioka, Kota Kawase, et al.
Targeted Oncology|April 22, 2026
First-Line Therapy for Advanced Renal Cell Carcinoma: Score-Matched Analysis of Dual Combination Immunotherapy versus Combination of Tyrosine Kinase Inhibitors and Immunotherapy in the TOURS Multicenter StudyHiromitsu Watanabe, Keita Nakane, Takuhisa Nukaya, et al.
Pageof 32